Addition Therapeutics
San Francisco, California, United States · Biotechnology, Health Care · 35 employees
Addition Therapeutics is a San Francisco-based genomic medicine company developing an all-RNA, non-viral, LNP-based PRINT platform. The company is focused on advancing a pipeline of PRINTed therapeutics for chronic and rare diseases. It is a spin-out of Professor Kathleen Collins’ laboratory at the University of California. Addition Therapeutics aims to use its funding to expand operations and res
Funding history
- Funding Round — $28.0M — Dec 2025
- Funding Round — $100.0M — Dec 2025
Recent signals
- Dec 22, 2025: Raised $28.0M
- Dec 18, 2025: Raised $100.0M
See plans & pricing → Track Addition Therapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.